3-D Bonelike Composites
A R T I C L E S
templating and inhibitory roles.8,9 Presumably, the acidic groups
serve as binding sites for calcium ions and align them in an
materials that integrate organic scaffolds and HA, and demon-
strate the level of integration of natural bone, have not yet been
achieved.
1
0,11
orientation that matches the apatite crystal lattice.
The
detailed mechanism of the formation and remodeling of natural
bone has long been a debate and is still subject to intensive
investigations. However, it is clear that template-driven biom-
ineralization, regulated by a number of extracellular matrix
components and the participation of bone cells, plays an
important role in formation of the highly integrated composite
structure of bone. This is the critical feature that the biomimetic
synthesis of artificial bone should emulate. We hypothesize that
this can be realized by the generation of functional polymer
scaffolds displaying surface ligands that mimic critical extra-
cellular matrix components known to direct template-driven
Hydrogel polymers are particularly appealing candidates for
the design of highly functional tissue engineering scaffolds.
27,28
The intrinsic elasticity and water retention ability of synthetic
hydrogels resemble those of natural hydrogels, such as collagen
matrices that are prevalent as structural scaffolds in various
27
connective tissues including bone. The porosity of synthetic
hydrogels may be controlled by various techniques including
29,30
31
solvent casting/particulate leaching,
phase separation, gas
32
33
34
foaming, solvent evaporation, freeze-drying, and blending
with non-crosslinkable linear polymers to afford a range of
35
mechanical properties. Another important feature of hydrogels
is that they can be assembled in 3-dimensional form displaying
multiple functional domains through copolymerization of dif-
ferent monomers. The polymerization chemistry is water
compatible, allowing incorporation of polar ligands such as
anionic peptides that mimic the acidic matrix proteins regulating
biomineralization, or to stimulate or assist cell adhesion,
proliferation, migration, and differentiation.1
2-15
Ideally, such
3
-dimensional scaffolds should also possess proper physical
properties, such as desired porosity and water retention ability,
to allow both pre-implantation cell seeding and post-implantation
tissue ingrowth.
mineral growth, and biological epitopes such as the tripeptide
There has been considerable effort to mimic bone by the
mineralization of polymer films with hydroxyapatite (HA) (Ca10-
36-38
RGD
that promote cellular adhesion.
Poly(2-hydroxyethyl methacrylate), or pHEMA, is one of the
(PO4)6(OH)2), the major inorganic component of natural bone.
3
9
most well-studied synthetic hydrogel polymers. With its high
biocompatibility, pHEMA and its functionalized copolymers
have become some of the most widely used synthetic hydrogels
in tissue engineering. Applications include ophthalmic devices
This is usually attempted through the time-consuming incubation
of substrates with simulated body fluid (SBF).16 This leads to
slow growth of crystalline or amorphous biominerals that exhibit
poor adhesion and lack a structural relationship with the
4
0,41
42
substrate.1
6-18
(e.g., contact lens),
cartilage replacements, bonding agents
Efforts aimed at improving the interface of HA
43-45
1
9,20
in dental resins and bone cements, and various drug delivery
One of the major challenges for its application as
with polymers include the use of silane coupling agents,
zirconyl salts, polyacids,
4
6,47
2
1
22,23
24,25
vehicles.
and isocyanates.
Recently,
a 3-dimensional scaffold of artificial bonelike materials, how-
ever, is to realize a high-affinity integration of inorganic minerals
with the organic pHEMA-based scaffold. This will be required
to achieve a composite material with unique mechanical
chemical treatment of biodegradable poly(lactide-co-glycolide)
films with aqueous base has been shown to facilitate the growth
of crystalline carbonate apatite on the surface.26 Both the
morphology and the thickness of the resulting crystalline apatite
layer, however, suggest that it will suffer from inadequate
interfacial adhesion (between the mineral and the polymer
substrate) and poor mechanical properties. Overall, composite
(
27) Peppas, N. A. Hydrogels in Medicine and Pharmacy; CRC Press: Boca
Raton, 1986.
(28) Lee, K. Y.; Mooney, D. J. Chem. ReV. 2001, 101, 1869-1879.
(
29) Holy, C. E.; Shoichet, M. S.; Davies, J. E. J. Biomed. Mater. Res. 2000,
51, 376-382.
(
8) Raj, P. A.; Johnson, M.; Levine, J. M.; Nancollas, H. G. J. Biol. Chem.
(30) Mooney, D. J.; Cima, L.; Langer, R.; Johnson, L.; Hansen, L. K.; Ingber,
D. E.; Vacanti, J. P. Mater. Res. Soc. Symp. Proc. 1992, 252, 345-352.
(31) Klawitter, J. J.; Hulbert, S. F. J. Biomed. Mater. Res. Symp. 1971, 2, 161-
229.
1
992, 267, 5968-5976.
(
9) Clark, R. H.; Campbell, A. A.; Klumb, L. A.; Long, C. J.; Stayton, P. S.
Calcif. Tissue Int. 1999, 64, 516-521.
(
(
10) Addadi, L.; Weiner, S. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 4110-
(32) Harris, L. D.; Kim, B.-S.; Mooney, D. J. J. Biomed. Mater. Res. 1998, 42,
396-402.
(33) Mikos, A. G.; Sarakinos, G.; Leite, S. M.; Vacanti, J. P.; Langer, R.
Biomaterials 1993, 14, 323-330.
(34) Whang, K.; Healy, K. E. In Methods of Tissue Engineering; Atala, A.,
Lanza, R. P., Eds.; Academic Press: San Diego, San Francisco, New York,
Boston, London, Sydney, Tokyo, 2002; pp 697-704.
(35) Brauker, J. H.; Carr-Brendel, V. E.; Martinson, L. A.; Crudele, J.; Johnston,
W. D.; Johnson, R. C. J. Biomed. Mater. Res. 1995, 29, 1517-1524.
(36) Massia, S. P.; Hubbell, J. A. Ann. N. Y. Acad. Sci. 1990, 589, 261-270.
(37) Barrera, D. A.; Zylstra, E.; Lansbury, P. T.; Langer, R. J. Am. Chem. Soc.
1993, 115, 11 010-11 011.
(38) Ratner, B. D. J. Mol. Recognit. 1996, 9, 617-625.
(39) Kost, J.; Langer, R. In Hydrogels in Medicine and Pharmacy; Peppas, N.,
Ed.; CRC Press: Boca Raton, 1987; Vol. III, p 95.
(40) Phillips, A. J.; Stone, J. Contact Lenses; Butterworth & Co.: London,
Boston, 1989.
4
114.
11) George, A.; Bannon, L.; Sabsay, B.; Dillon, J. W.; Malone, J.; Veis, A.;
Jenkins, N. A.; Gillbert, D. J.; Copeland, N. G. J. Biol. Chem. 1996, 271,
3
2 869-32 873.
(
(
(
(
12) Shea, L. D.; Smiley, E.; Bonadio, J.; Mooney, D. J. Nat. Biotechnol. 1999,
7, 551-554.
13) Lee, K. Y.; Peters, M. C.; Anderson, K. W.; Mooney, D. J. Nature 2000,
08, 998-1000.
14) Mann, B. K.; Schmedlen, R. H.; West, J. L. Biomaterials 2001, 22, 439-
44.
15) Luo, Y.; Dalton, P. D.; Shoichet, M. S. Chem. Mater. 2001, 13, 4087-
1
4
4
4
093.
(
(
(
16) Kokubo, T. Acta Mater. 1998, 46, 2519-2527.
17) Rhee, S.-H.; Tanaka, J. Biomaterials 1999, 20, 2155-2160.
18) Saiz, E.; Goldman, M.; Gomez-Vega, J. M.; Tomsia, A. P.; Marshall, G.
W.; Marshall, S. J. Biomaterials 2002, 23, 3749-3756.
(
(
19) Labella, R.; Braden, M.; Deb, S. Biomaterials 1994, 15, 1197-1200.
20) Dupraz, A. M. P.; de Wijn, J. R.; vander Meer, S. A. T.; de Groot, K. J.
Biomed. Mater. Res. 1996, 30, 231-238.
(41) Kidane, A.; Sxabocsik, J. M.; Park, K. Biomaterials 1998, 19, 2051-2055.
(42) Oxley, H. R.; Corkhill, P. H.; Fitton, J. H.; Tighe, B. J. Biomaterials 1993,
14, 1064-1072.
(
(
21) Misra, D. N. J. Dent. Res. 1985, 12, 1405-1408.
(43) Vermeiden, J. P. W.; Rejda, B. B.; Peelen, J. G. J.; de Groot, K. In
EValuation of Biomaterials; Winter, G. D., Leray, J. L., de Groot, K., Eds.;
Wiley: New York, 1980; pp 405-411.
22) Bradt, J.-H.; Mertig, M.; Teresiak, A.; Pompe, W. Chem. Mater. 1999, 11,
2
694-2701.
(
(
(
(
23) Liu, Q.; de Wijn, J. R.; Bakker, D.; van Toledo, M.; van Blitterswijk, C.
(44) Yang, J. M.; You, J. W.; Chen, H. L.; Shih, C. H. J. Biomed. Mater. Res.
1996, 33, 83-88.
A. J. Mater. Sci.-Mater. Med. 1998, 9, 23-30.
24) Liu, Q.; de Wijn, J. R.; van Blitterswijk, C. A. J. Biomed. Mater. Res.
(45) Prati, C.; Mongiorgi, R.; Valdre, G.; Montanary, G. Clin. Mater. 1991, 8,
137-143.
1
998, 40, 257-263.
25) Liu, Q.; de Wijn, J. R.; van Blitterswijk, C. A. J. Biomed. Mater. Res.
998, 40, 358-364.
26) Murphy, W. L.; Mooney, D. J. J. Am. Chem. Soc. 2002, 124, 1910-1917.
(46) Lu, S.; Anseth, K. S. J. Controlled Release 1999, 57, 291-300.
(47) Sefton, M. V.; May, M. H.; Lahooti, S.; Babensee, J. E. J. Controlled
Release 2000, 65, 173-186.
1
J. AM. CHEM. SOC.
9
VOL. 125, NO. 5, 2003 1237